Radiofrequency-Based Systems Account for 75% of Renal Denervation Technology Revenue Share: Fact.MR Study



Emergence of micro-infusion technology, continuous research and development initiatives for the improvement of healthcare systems, and increasing adoption of advanced renal denervation systems are factors driving the growth of the market

United States, Rockville MD, Aug. 11, 2022 (GLOBE NEWSWIRE) — According to in-depth industry analysis by Fact.MR, a market research and competitive intelligence provider, the global renal denervation technology market is expected to grow at a stellar CAGR of 40% from 2022 to 2026.

The growing prevalence of lifestyle disorders such as hypertension due to an increase in sedentary and stressful lifestyles, alcohol and tobacco consumption, poor dietary habits and the increase in the elderly population are driving the market expansion. The advantages of renal denervation technologies such as rapid recovery, safety, convenience, and cost-effectiveness act as significant growth factors.

For critical information on Renal denervation technologies Market, demand a Sample Report

Catheter-based procedures to remove renal nerves have demonstrated significant results. In addition, catheter-based techniques appear to be less risky for patients and facilitate the denervation of certain nerves. Factors projected to propel growing demand for renal denervation technologies are an increased prevalence of hypertension with ineffective antihypertensive drugs, a lasting effect of renal denervation, and steady advances in renal denervation devices.

Due to benefits such as improved safety, shorter treatment times, permanent effects, and an increase in uncontrolled and treatment-resistant hypertension in the urban population due to changing lifestyles, The market for renal denervation technologies and related processes is set to increase at a rapid rate in the coming years.

What is shaping the growth of the Renal Denervation Technologies market?

“Increased funding for R&D initiatives for the treatment of kidney disorders”

The demand for renal denervation procedures is expected to be supported by various government authorities and organizations increasing funding for R&D initiatives for the treatment of renovascular hypertension. Additionally, advancements in renal denervation devices could propel the industry.

One of the key factors increasing adoption of the renal denervation method is the number of new skills it introduces. The disadvantages of high frequency renal denervation systems can be overcome by an ultrasound RDN device. Without touching tissue directly, high frequency sound waves and ultrasonic energy help clear nerves.

This reduces the risk of renal artery damage. This quality makes this method preferred by a significant number of patients around the world. The effectiveness of these strategies will also be greatly enhanced by incorporating technology into these types of health practices and opening up the opportunities in the renal denervation industry.

To learn more about Renal denervation technologies Market, you can contact our analyst at

Key segments covered by the Renal denervation technologies Industry survey

  • By product:

    • Symplicity

    • Vessix

    • EnlightHTN

    • Heaven

    • Iberis

    • Others

  • By technology:

    • Based on radio frequency

    • Based on ultrasound

    • Based on micro-infusion

  • Per end user:

  • By region:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East and Africa

Winning strategy

Renal denervation device manufacturing companies are taking steps to increase their presence in the global market such as innovative product launches and collaborations. Large companies are making significant investments to differentiate themselves from each other and thrive in today’s market environment. Market players are also encouraged to use creative marketing techniques to promote the use of renal denervation devices.

For instance,

  • In 2021, the Paradise Ultrasonic Renal Denervation System was introduced by ReCor Medical. The special product should simplify the diagnosis of patients with uncontrolled hypertension throughout Germany.

Get customization on Renal denervation technologies Market Report for specific search solutions

The key players in the Renal denervation technologies Market

Main takeaways from Renal denervation technologies Market research

  • The global renal denervation technologies market is expected to reach a valuation of US$720 million by 2026.

  • The market in Germany is expected to grow at a CAGR of 33% over the forecast period.

  • The demand for ultrasound-based technologies is expected to grow by 37% CAGR through 2026.

  • The market in Canada is expected to grow at a CAGR of 36% from 2022 to 2026.

Check out Fact.MR’s coverage on the Health care Domain-

Recombinant Protein Market – The proteins resulting from the expression of recombinant DNA (rDNA), within living cells, are called recombinant proteins. rDNAs are DNA molecules that are formed by genetic recombination laboratory procedures, to bring together genetic material from multiple sources.

gas chromatography market – Gas chromatography (GC) is used for the analysis and separation of compounds capable of vaporizing without undergoing decomposition. GC is used to test the purity of substances, by separating the components of a mixture. Gas chromatography is also used to prepare pure compounds from mixtures and to identify compounds.

diabetic food market – Diabetes Food Market Share and Trend Analysis, by Nature (Organic, Conventional), by Type (Bakery, Dairy, Other), by Distribution Channel (Direct, Indirect) and by Region – Market Overview world 2018 to 2028

Urodynamic Devices Market – The main objective of a urodynamic test is to understand the disorders/problems occurring in the lower urinary tract by duplication of symptoms. The urodynamic study also helps to determine the causes of bladder dysfunction, formulating an appropriate course for treatment.

Antibody market – The global demand for antibodies should remain moderate in the coming years. The increasing prevalence of chronic diseases such as autoimmune diseases, cancer, diabetes and others is encouraging manufacturers to invest more in antibody R&D activities.

Amniocentesis Needles Market – Demand for amniocentesis needles is expected to accelerate due to the growing need to remove excess amniotic fluid around the baby. Excess amniotic fluid during pregnancy leads to increased risks of complications.

prefilled syringes market – The global prefilled syringes market is expected to grow at a CAGR of almost 10% from 2021 to 2031. The short-term forecast looks equally lucrative, recording a growth rate of 9.6% through 2026.

Actigraphy PSG Sensors and Devices Market – The market for actigraphy sensors and PSG devices is experiencing positive growth, with the leaders accounting for nearly two-thirds of total market revenue. Market pioneers in actigraphy sensors and PSG devices including Koninklijke Philips NV, Fitbit, Inc., Garmin Ltd. and ResMed Inc., have maintained a strong presence in the market.

Lithotripsy Devices Market – The market for lithotripsy devices is expected to surpass US$2 billion by 2031, growing at a CAGR of over 5%. The market is largely driven by the increased prevalence of urolithiasis, an increase in the number of extracorporeal shock wave lithotripsy operations, technical developments and growing awareness.

About Us:
Market research and consulting agency that makes the difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. Although our experienced consultants use the latest technology to extract hard-to-find information, we believe that our USP is the trust our clients place in our expertise. Covering a wide spectrum – from automotive and Industry 4.0 to healthcare and retail, our coverage is extensive, but we ensure that even the most niche categories are analyzed. Our sales offices in the USA and Dublin, Ireland. Headquarters based in Dubai, United Arab Emirates. Contact us with your goals and we will be a competent research partner.

Mahendra Singh
USA Sales Office:
11140 Rockville Pike
Office 400
Rockville, MD 20852
Tel: +1 (628) 251-1583
Follow us: LinkedIn | Twitter


Comments are closed.